These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8355071)

  • 1. Antimyosin positivity in doxorubicin cardiotoxicity: earlier than the conventional evidence.
    Narula J; Strauss HW; Khaw BA
    J Nucl Med; 1993 Sep; 34(9):1507-9. PubMed ID: 8355071
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?
    Jain D; Zaret BL
    J Nucl Med; 1990 Dec; 31(12):1970-4. PubMed ID: 2266395
    [No Abstract]   [Full Text] [Related]  

  • 4. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.
    Carrió I; Estorch M; Berná L; López-Pousa J; Tabernero J; Torres G
    J Nucl Med; 1995 Nov; 36(11):2044-9. PubMed ID: 7472595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer.
    Estorch M; Carrió I; Berná L; Martínez-Duncker C; Alonso C; Germá JR; Ojeda B
    J Nucl Med; 1990 Dec; 31(12):1965-9. PubMed ID: 2266394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin cardiotoxicity detected by indium 111 myosin-specific imaging.
    Lekakis J; Vassilopoulos N; Psichoyiou H; Athanassiadis P; Gerali S; Kostamis P; Moulopoulos S
    Eur J Nucl Med; 1991; 18(3):225-6. PubMed ID: 1645666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of adriamycin cardiotoxicity with indium-111 labeled antimyosin monoclonal antibody imaging.
    Yamada T; Matsumori A; Tamaki N; Morishima S; Watanabe Y; Yonekura Y; Endo K; Konishi J; Kawai C
    Jpn Circ J; 1991 Apr; 55(4):377-83. PubMed ID: 2046143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [111In-antimyosin Fab myocardial scintigraphy].
    Nishimura T; Nagata S
    Nihon Rinsho; 1991 Jan; 49(1):130-6. PubMed ID: 2002591
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclide ventriculography for evaluation and prevention of doxorubicin cardiotoxicity.
    Steinberg JS; Wasserman AG
    Clin Ther; 1985; 7(6):660-7. PubMed ID: 3907840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardial and myocardial localization of antimyosin in a case of acute myocarditis.
    Castell J; Fraile M; Garcia A; Encabo G; Cortadellas J; Galve E; Candell J
    J Nucl Med; 1994 Mar; 35(3):469-70. PubMed ID: 8113899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac gallium uptake in doxorubicin-induced cardiotoxicity.
    Hatfield MK; Martin WB; Ryan JW; Vokes EE; Vogelzang NJ
    Clin Nucl Med; 1986 Nov; 11(11):756-7. PubMed ID: 3791781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of anthracycline-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studies.
    Carrió I; Estorch M; Berná L; Germá JR; Alonso C; Ojeda B; de Andrés L; Lopez-Pousa A; Martinez-Duncker C; Torres G
    Eur J Nucl Med; 1991; 18(10):806-12. PubMed ID: 1743203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-labelled antimyosin antibody imaging in a patient with cardiac sarcoidosis.
    Knapp WH; Bentrup A; Ohlmeier H
    Eur J Nucl Med; 1993 Jan; 20(1):80-2. PubMed ID: 8420786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective right ventricular dysfunction following doxorubicin therapy.
    Sperber AD; Cantor AA; Biran H; Keynan A
    Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indium-111-antimyosin for the evaluation of myocardial damage in patients with suspected myocarditis and cardiac rejection].
    Carrió I; Berná L; Ballester M; Obrador D; Abadal L; Estorch M; Cladellas M; Ginjaume M
    Rev Esp Cardiol; 1988; 41 Suppl 2():70-6. PubMed ID: 3070667
    [No Abstract]   [Full Text] [Related]  

  • 17. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation.
    Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G
    J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-111 monoclonal antimyosin for diagnosis of cardiac rejection.
    Schütz A; Fritsch S; Kugler C; Anthuber M; Sudhoff F; Wenke K; Spes C; Angermann C; Gokel JM; Kemkes BM
    Transplant Proc; 1990 Aug; 22(4):1464-5. PubMed ID: 2389366
    [No Abstract]   [Full Text] [Related]  

  • 19. Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value.
    Yamada T; Tamaki N; Morishima S; Konishi J; Yoshida A; Matsumori A
    J Nucl Med; 1992 Aug; 33(8):1501-8. PubMed ID: 1634942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cyclosporine toxic to the heart?
    Owunwanne A; Shihab-Eldeen A; Sadek S; Junaid T; Yacoub T; Abdel-Dayem HM
    J Heart Lung Transplant; 1993; 12(2):199-204. PubMed ID: 8476891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.